← Leaderboards
Domenico Pratico
Temple Univ Of The Commonwealth
$19,283,755
Attributed
$20,656,981
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,656,981 · 14
By mechanism
R01$11,988,169 · 7
RF1$7,893,750 · 4
R21$420,750 · 1
P01$195,812 · 1
R03$158,500 · 1
Top collaborators
- Theodore R Holman5 shared
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Nicholas Lyssenko$1,771,516
- Pooja Jadiya$1,560,433
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposPhenotypeBrainMouse ModelS DiseasePathogenesisNerve DegenerationPlayDementiaNovel TherapeuticsCellsBehavioralNeuropathologyPathologyProteinsMediatingNeuronsEventPathway InteractionsIn VivoLinkBehavioral ImpairmentPreventSenile Plaques
Grant awards (42)
Proteostasis dysregulation and the development of Alzheimer's-like neurodegeneration and dementia in Down syndrome$532,856
R01 · FY2025 · AG · contact PI
Alzheimer's tauopathy phenotype and the microRNA22-3p: implication for pathogenesis$498,758
R01 · FY2025 · AG · contact PI
Proteostasis dysregulation and the development of Alzheimer's-like neurodegeneration and dementia in Down syndrome$529,653
R01 · FY2024 · AG · contact PI
Alzheimer's tauopathy phenotype and the microRNA22-3p: implication for pathogenesis$523,202
R01 · FY2024 · AG · contact PI
Proteostasis dysregulation and the development of Alzheimer's-like neurodegeneration and dementia in Down syndrome$523,313
R01 · FY2023 · AG · contact PI
Alzheimer's tauopathy phenotype and the microRNA22-3p: implication for pathogenesis$485,796
R01 · FY2023 · AG · contact PI
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease$534,417
R01 · FY2022 · AG
Alzheimer's tauopathy phenotype and the microRNA22-3p: implication for pathogenesis$461,070
R01 · FY2022 · AG · contact PI
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease$540,683
R01 · FY2021 · AG
Alzheimer's tauopathy phenotype and the microRNA22-3p: implication for pathogenesis$462,655
R01 · FY2021 · AG · contact PI
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease$546,768
R01 · FY2020 · AG
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease$552,677
R01 · FY2019 · AG
Maternal lifestyle, brain aging and Alzheimer's disease$1,981,250
RF1 · FY2018 · AG · contact PI
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease$571,908
R01 · FY2018 · AG
Vps35 dysregulation, a mechanism of AD-like neurodegeneration and dementia in Down syndrome$1,981,250
RF1 · FY2017 · AG · contact PI
Aging, the retromer complex and the neurobiology of Alzheimer's disease$1,981,250
RF1 · FY2017 · AG · contact PI
Dissecting the role of 5LO in neurodegeneration associated with homocysteine$1,950,000
RF1 · FY2016 · AG · contact PI
5Lipoxygenase-mediated vasculopathy in HHcy$390,000
R01 · FY2016 · HL · contact PI
5Lipoxygenase-mediated vasculopathy in HHcy$384,150
R01 · FY2015 · HL · contact PI
5Lipoxygenase-mediated vasculopathy in HHcy$381,792
R01 · FY2014 · HL · contact PI
The Neurobiology of 5-Lipoxygenase$295,569
R01 · FY2014 · AG · contact PI
5Lipoxygenase-mediated vasculopathy in HHcy$368,900
R01 · FY2013 · HL · contact PI
The Neurobiology of 5-Lipoxygenase$279,312
R01 · FY2013 · AG · contact PI
The Neurobiology of 5-Lipoxygenase$295,569
R01 · FY2012 · AG · contact PI
The functional role of FLAP in Alzheimer's Disease$191,250
R21 · FY2012 · NS · contact PI
The Neurobiology of 5-Lipoxygenase$295,569
R01 · FY2011 · AG · contact PI
The functional role of FLAP in Alzheimer's Disease$229,500
R21 · FY2011 · NS · contact PI
The Neurobiology of 5-Lipoxygenase$307,500
R01 · FY2010 · AG · contact PI
Oxidative stress, Homocysteine and Alzheimer's Disease$223,013
R01 · FY2008 · AG · contact PI
The neurobiology of 12/15 lipoxygenase$225,000
R01 · FY2007 · AG · contact PI
Oxidative stress, Homocysteine and Alzheimer's Disease$165,301
R01 · FY2007 · AG · contact PI
Oxidative stress, Homocysteine and Alzheimer's Disease$75,158
R01 · FY2007 · AG · contact PI
The neurobiology of 12/15 lipoxygenase$18,464
R01 · FY2007 · AG · contact PI
The neurobiology of 12/15 lipoxygenase$250,736
R01 · FY2006 · AG · contact PI
Oxidative stress, Homocysteine and Alzheimer's Disease$247,640
R01 · FY2006 · AG · contact PI
LIPID PEROXIDATION AND ALZHEIMERS DISEASE PHENOTYPES$195,812
P01 · FY2006 · AG · contact PI
The neurobiology of 12/15 lipoxygenase$256,770
R01 · FY2005 · AG
Oxidative stress, Homocysteine and Alzheimer's Disease$253,600
R01 · FY2005 · AG
The neurobiology of 12/15 lipoxygenase$256,770
R01 · FY2004 · AG
Oxidative stress, Homocysteine and Alzheimer's Disease$253,600
R01 · FY2004 · AG
Effects of Dietary Aluminum on Amyloidosis in a Transge*$79,250
R03 · FY2002 · ES
Effects of Dietary Aluminum on Amyloidosis in a Transge*$79,250
R03 · FY2001 · ES